Wird geladen...
Balancing Risks and Benefits of Therapy for Patients with Favorable-Risk Limited-Stage Hodgkin Lymphoma: The Role of ABVD Chemotherapy Alone
More than 85% of patients with non-bulky stage IA-IIA Hodgkin lymphoma will obtain long-term disease control. However, as long-term survival is dependent on both disease control and avoidance of late toxic effects associated with the treatment received, the initial choice of treatment can be associa...
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
2014
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3859248/ https://ncbi.nlm.nih.gov/pubmed/24287067 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.hoc.2013.10.001 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|